BSX-PA Stock Price, Chart, Stats & News

Boston Scientific Corporation
Save
175.45B
Market cap
230.53x
Current P/E
–
Forward P/E
BSX-PA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.01% |
Operating margin | 19.78% |
Pretax margin | 16.86% |
Net margin | 14.40% |
Effective tax rate | 14.56% |
ROA | 6.62% |
ROE | 12.53% |
D/E | 0.51x |
Interest coverage ratio | 11.22x |
BSX-PA valuation
P/E | 230.53x |
P/S | 5.11x |
P/B | 4.23x |
P/CF | 22.62x |
P/FCF | 28.31x |
P/OCF | 22.62x |
PEG | 9.58x |
EV multiple | 18.80x |
About
Boston Scientific Corporation designs, produces, and distributes medical devices globally for a broad spectrum of interventional medical fields. The company's operations are structured across three primary segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Its MedSurg portfolio offers solutions for diagnosing and managing conditions affecting the gastrointestinal and pulmonary systems, as well as addressing urological and pelvic health issues.
Similar securities
Based on sector and market capitalization
Report issue











